Retinopathy of Prematurity

• 

  Subject Areas on Research

  • A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. 
  • A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. 
  • A hybrid method in combining treatment effects from matched and unmatched studies. 
  • A numeric index based on spatial frequency for the tortuosity of retinal vessels and its application to plus disease in retinopathy of prematurity. 
  • A pilot study using "ROPtool" to quantify plus disease in retinopathy of prematurity. 
  • A pilot study using ROPtool to measure retinal vascular dilation. 
  • Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. 
  • Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. 
  • Angiotensin II and aldosterone in retinal vasculopathy and inflammation. 
  • Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis. 
  • Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). 
  • Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. 
  • Association Between Retinal Microanatomy in Preterm Infants and 9-Month Visual Acuity. 
  • Association between Policy Changes for Oxygen Saturation Alarm Settings and Neonatal Morbidity and Mortality in Infants Born Very Preterm. 
  • Auto-Processed Retinal Vessel Shadow View Images From Bedside Optical Coherence Tomography to Evaluate Plus Disease in Retinopathy of Prematurity. 
  • Bevacizumab for retinopathy of prematurity. 
  • Birth Weight Is a Significant Predictor of Retinal Nerve Fiber Layer Thickness at 36 Weeks Postmenstrual Age in Preterm Infants. 
  • Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity. 
  • Clinical course and systemic correlates of retinopathy of prematurity in quintuplets. 
  • Combining ROPtool measurements of vascular tortuosity and width to quantify plus disease in retinopathy of prematurity. 
  • Competency checklists for strabismus surgery and retinopathy of prematurity examination. 
  • Computer-assisted assessment of plus disease in retinopathy of prematurity using video indirect ophthalmoscopy images. 
  • Computer-assisted measurement of retinal vascular width and tortuosity in retinopathy of prematurity. 
  • Computer-assisted quantification of pre-plus and plus disease in images obtained using Pictor versus video indirect ophthalmoscopy: a pilot study. 
  • Cost comparison of using reusable versus disposable equipment for retinopathy of prematurity screening rounds. 
  • Delay in retinal photoreceptor development in very preterm compared to term infants. 
  • Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials. 
  • Development of a scale for grading pre-plus and plus disease using retinal images: A pilot study. 
  • Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. 
  • Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin. 
  • Differentials and approach to leukocoria. 
  • Differentiating Retinal Detachment and Retinoschisis Using Handheld Optical Coherence Tomography in Stage 4 Retinopathy of Prematurity. 
  • Early CPAP versus surfactant in extremely preterm infants. 
  • Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group. 
  • Effect of Cord Blood Magnesium Level at Birth on Non-neurologic Neonatal Outcomes. 
  • Effect of cyclooxygenase inhibition on retinal and choroidal blood flow during hypercarbia in newborn piglets. 
  • Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial. 
  • Environmental oxygen regulates astrocyte proliferation to guide angiogenesis during retinal development. 
  • Evaluating the association of clinical factors and optical coherence tomography retinal imaging with axial length and axial length growth among preterm infants. 
  • Evaluation of Screening for Retinopathy of Prematurity by ROPtool or a Lay Reader. 
  • Evaluation of an indirect ophthalmoscopy digital photographic system as a retinopathy of prematurity screening tool. 
  • Evaluation of optic nerve development in preterm and term infants using handheld spectral-domain optical coherence tomography. 
  • Evaluation of the accuracy of grading indirect ophthalmoscopy video images for retinopathy of prematurity screening. 
  • Evolution of plus disease in retinopathy of prematurity: quantification by ROPtool. 
  • Experimental Evidence Behind Clinical Trial Outcomes in Retinopathy of Prematurity. 
  • Facilitated Versus Self-guided Training of Non-ophthalmologists for Grading Pre-plus and Plus Disease Using Fundus Images for Retinopathy of Prematurity Screening. 
  • Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity. 
  • Fluorescein Angiographic Characteristics of Macular Edema During Infancy. 
  • Foveal Differentiation and Inner Retinal Displacement Are Arrested in Extremely Premature Infants. 
  • Foveal avascular zone and foveal pit formation after preterm birth. 
  • Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. 
  • Genomics in the neonatal nursery: Focus on ROP. 
  • HANDHELD SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGING THROUGH THE UNDILATED PUPIL IN INFANTS BORN PRETERM OR WITH HYPOXIC INJURY OR HYDROCEPHALUS. 
  • Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. 
  • Hyperoxemic retinal necrosis in the premature neonate. 
  • Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. 
  • Incidence of retinopathy of prematurity in the United States: 1997 through 2005. 
  • Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. 
  • Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. 
  • Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants. 
  • Integrated Visualization Highlighting Retinal Changes in Retinopathy of Prematurity From 3-Dimensional Optical Coherence Tomography Data. 
  • International Classification of Retinopathy of Prematurity, Third Edition. 
  • Intranasal midazolam and fentanyl for procedural sedation and analgesia in infants in the neonatal intensive care unit. 
  • Introduction. 
  • Long-term visual results of children after initially successful vitrectomy for stage V retinopathy of prematurity. 
  • Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. 
  • Macular OCT Characteristics at 36 Weeks' Postmenstrual Age in Infants Examined for Retinopathy of Prematurity. 
  • Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. 
  • Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. 
  • Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. 
  • Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. 
  • Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment. 
  • Neurodevelopmental outcome of infants with unilateral or bilateral periventricular hemorrhagic infarction. 
  • Non-contact retinal imaging compared to indirect ophthalmoscopy for retinopathy of prematurity screening: infant safety profile. 
  • Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. 
  • OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEA IN CHILDREN BORN PRETERM. 
  • Observer sensitivity to retinal vessel diameter and tortuosity in retinopathy of prematurity: a model system. 
  • Optical coherence tomography in retinopathy of prematurity: looking beyond the vessels. 
  • Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. 
  • Parents' Knowledge and Education of Retinopathy of Prematurity in Four California Neonatal Intensive Care Units. 
  • Phthisis bulbi after lensectomy in retinopathy of prematurity eyes previously treated with laser photocoagulation. 
  • Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants. 
  • Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery. 
  • Posterior Pole Vascular Changes Before Treatment of Retinopathy of Prematurity. 
  • Predicting the need for laser treatment in retinopathy of prematurity using computer-assisted quantitative vascular analysis. 
  • Predictive value of pre-plus disease in retinopathy of prematurity. 
  • Preterm Infant Stress During Handheld Optical Coherence Tomography vs Binocular Indirect Ophthalmoscopy Examination for Retinopathy of Prematurity. 
  • Preterm infants born at less than 31 weeks' gestation have improved growth in cycled light compared with continuous near darkness. 
  • Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity. 
  • Quantitative comparison of blood vessel changes after treatment of retinopathy of prematurity with laser versus bevacizumab. 
  • Quantitatively comparing weekly changes in retinal vascular characteristics of eyes eventually treated versus not treated for retinopathy of prematurity. 
  • ROPtool analysis of images acquired using a noncontact handheld fundus camera (Pictor)--a pilot study. 
  • ROPtool analysis of plus and pre-plus disease in narrow-field images: a multi-image quadrant-level approach. 
  • Re: Nudleman et al.: Glaucoma after lens-sparing vitrectomy for advanced retinopathy of prematurity (Ophthalmology. 2018;125:671-675). 
  • Real-World Simulation of an Alternative Retinopathy of Prematurity Screening System in Thailand: A Pilot Study. 
  • Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. 
  • Refractive errors and strabismus in premature Asian infants with and without retinopathy of prematurity. 
  • Retinal imaging in premature infants using the Pictor noncontact digital camera. 
  • Retinal neovascular markers in retinopathy of prematurity: aetiological implications. 
  • Retinal vessels and retinopathy of prematurity. 
  • Retinopathy of prematurity care: patterns of care and workforce analysis. 
  • Retinopathy of prematurity classification updates: possible implications for treatment. 
  • Retinopathy of prematurity in the United States. 
  • Retinopathy of prematurity risk prediction for infants with birth weight less than 1251 grams. 
  • Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring. 
  • Retinopathy of prematurity. Diagnosis, severity, and natural history. 
  • Retinopathy of prematurity: late complications in the baby boomer generation (1946-1964). 
  • Retinopathy of prematurity: the disease process, classifications, screening, treatment, and outcomes. 
  • Risk of development of treated retinopathy of prematurity in very low birth weight infants. 
  • SHORT-TERM COMPUTER-ASSISTED QUANTIFICATION OF PLUS DISEASE AFTER TREATMENT OF TYPE 1 RETINOPATHY OF PREMATURITY WITH INTRAVITREAL BEVACIZUMAB OR RETINAL LASER PHOTOCOAGULATION. 
  • Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. 
  • Sample size for comparing correlated concordance rates. 
  • Screening examination of premature infants for retinopathy of prematurity. 
  • Screening examination of premature infants for retinopathy of prematurity. 
  • Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity. 
  • Seeing stars: Development and function of retinal astrocytes. 
  • Semi-automated vessel analysis of en face posterior pole vessel maps generated from optical coherence tomography for diagnosis of plus or pre-plus disease. 
  • Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. 
  • Significance of isolated neovascular tufts ("popcorn") in retinopathy of prematurity. 
  • Sildenafil and retinopathy of prematurity risk in very low birth weight infants. 
  • Single grading vs double grading with adjudication in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study. 
  • Slow progressive perifoveal vascular formation in an infant with aggressive posterior retinopathy of prematurity. 
  • Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. 
  • Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 12-month experience with telemedicine screening. 
  • Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 18-month experience with telemedicine screening. 
  • Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 24-month experience with telemedicine screening. 
  • Stanford University network for diagnosis of retinopathy of prematurity (SUNDROP): 36-month experience with telemedicine screening. 
  • Stanniocalcin-1 is a Modifier of Oxygen-Induced Retinopathy Severity. 
  • Target ranges of oxygen saturation in extremely preterm infants. 
  • The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. 
  • The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. 
  • Three-dimensional assessment of vascular and perivascular characteristics in subjects with retinopathy of prematurity. 
  • Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity. 
  • Tortuosity of arterioles and venules in quantifying plus disease. 
  • Transcutaneous oxygen monitoring and retinopathy of prematurity. 
  • Treatment of retinopathy of prematurity with argon laser photocoagulation. 
  • Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. 
  • Trends in Retinopathy of Prematurity Screening and Treatment: 2008-2018. 
  • Using video indirect ophthalmoscopy to demonstrate retinopathy of prematurity findings. 
  • Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study. 
  • Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. 
  • Vascular dilation and tortuosity in plus disease. 
  • Visualizing Macular Microvasculature Anomalies in 2 Infants With Treated Retinopathy of Prematurity. 
• 

  Keywords of People

  • Farsiu, Sina, Professor in the Department of Biomedical Engineering, Electrical and Computer Engineering
  • Prakalapakorn, Grace, Associate Professor of Ophthalmology, Pediatrics
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Toth, Cynthia Ann, Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology, Biomedical Engineering